Skip to main content

2020 News

2020 News | 2019 Archive | 2018 Archive | 2017 Archive | 2016 Archive | 2015 Archive


Thursday, January 16, 2020

University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care

Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.


Wednesday, January 15, 2020

New Nanoparticle Therapy Appears More Effective Than Standard Therapy at Treating Aggressive Breast Cancer

Researchers at the University of Maryland School of Medicine (UMSOM) developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells and appears to be more effective than a standard nanoparticle therapy currently on the market to treat metastatic breast cancer, according to a study published today in the journal Science Advances. The new ‘DART’ nanoparticles bypass healthy cells and tissues and bind to tumor cells, dispersing evenly throughout the tumor while releasing the chemotherapy drug paclitaxel.


Wednesday, January 15, 2020

Dr. Andrea Meredith’s Research is the Cover Story in The Physiologist Magazine

One night just before bed in August 2018, Andrea Meredith, PhD, was reading the New York Times Magazine on her iPad when she came across an article about a six-year-old girl in South Dakota named Kamiyah who had a mysterious disorder. Over 300 times a day, the little girl would fall or slump forward, with large portions of her body paralyzed. An episode would last anywhere from three to 20 seconds. Then, suddenly, she would pop back up and resume whatever she was doing. The article mentioned that Kamiyah had paroxysmal dyskinesia, a type of movement disorder. But the cause was unknown.


Monday, January 13, 2020

University of Maryland Medicine's Novel Critical Care Resuscitation Unit Improves Patients' Chances of Survival, Study Finds

Patients with acutely life-threatening health conditions who were treated in the innovative Critical Care Resuscitation Unit (CCRU) received faster treatment and had better health outcomes, including a 36 percent lower risk of dying than those who were transferred from a hospital’s emergency department then evaluated and treated in a traditional intensive care unit, according to a recent study in the Journal of Emergency Medicine conducted by researchers at the University of Maryland School of Medicine (UMSOM).


Thursday, January 09, 2020

UM School of Medicine Research Shows Less Severe Cases of Diarrheal Illness can Still Lead to Child Deaths, Even Weeks Following Onset of the Illness

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age. Now, researchers at the University of Maryland School of Medicine (UMSOM) found that even milder cases of diarrheal diseases can lead to death in young children.


Thursday, January 09, 2020

Researchers Identify Key Structure of Bacteria that Could Lead to Future Treatments for Healthcare-Associated Infections

Researchers from the University of Maryland School of Medicine and their colleagues have identified the structure of the most lethal toxin produced by certain strains of Clostridium difficile bacteria, a potentially deadly infection associated with the use of antibiotics. The finding, published last week in the Proceedings of the National Academy of Sciences journal, used cryo electron microscopy, X-ray crystallography and other biophysical methods to identify the microscopic structures of the bacteria. The researchers mapped out the delivery and binding components of the toxin, which could pave the way for new drugs to neutralize it.


Wednesday, January 08, 2020

UM School of Medicine Launches New Pathway to Promotion for Non-Tenure Track Faculty; Policy will Specifically Benefit Clinician-Educators and Administrators

UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that a new contemporary pathway to promotion has been created that will directly benefit faculty who are clinician-educators or clinician- administrators.  The new policy is based on a recent analysis of faculty promotions in UMSOM’s academic departments that revealed a gender disparity in promotion rates for some clinical faculty in clinical departments.